Otogenic CSVT Retrospective Case Series and Associated Thrombophilia (NCT03864055) | Clinical Trial Compass
CompletedNot Applicable
Otogenic CSVT Retrospective Case Series and Associated Thrombophilia
Israel9 participantsStarted 2018-12-02
Plain-language summary
The aim of this study is to report the clinical presentation, Microbiological, laboratory and imaging evaluation, prothrombotic factors analysis, medical and surgical management and outcomes in children with Otogenic Cerebral Sinus Vein Thrombosis (CSVT).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age of 18 years or younger
* both sexes are included
* a clinical or radiological finding of mastoiditis in the patient's file
* Documentation of CSVT in an imaging study, either CT or MRI.
Patient's exclusion criteria
* age above 18 years
* lack of a clinical or radiological finding of mastoiditis in the patient's file
* Lack of documentation of CSVT in an imaging study, either CT or MRI.
* previous unprovoked venous thromboembolism event.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Clinical Presentation
Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
2
Cultures result
Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
3
Morbidity and Mortality
Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
4
Surgical intervention
Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
5
Thrombophilia evaluation tests
Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee